Allarity Therapeutics, Inc.
ALLR
$1.52
-$0.16-9.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.19% | 18.49% | -106.98% | -88.86% | -105.99% |
| Total Depreciation and Amortization | -244.44% | -217.65% | 38.10% | -37.93% | -75.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.33% | -84.55% | 297.47% | 281.73% | 267.52% |
| Change in Net Operating Assets | -9,115.87% | 95.93% | -391.88% | -152.45% | -98.12% |
| Cash from Operations | 14.59% | 6.54% | -6.76% | -70.33% | -36.15% |
| Capital Expenditure | 97.32% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 97.32% | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | 27.62% |
| Total Debt Repaid | -- | 100.00% | 100.00% | 63.77% | 63.77% |
| Issuance of Common Stock | -62.95% | -47.00% | -48.00% | 152.67% | 95.18% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -- | -- | 153.28% |
| Repurchase of Preferred Stock | -- | 100.00% | 30.00% | 47.38% | 47.40% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -71.06% | -54.28% | -48.99% | 315.04% | 234.62% |
| Foreign Exchange rate Adjustments | -396.44% | -717.26% | -1,960.82% | 12.06% | 299.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -125.02% | -109.19% | -107.61% | 161,029.41% | 1,139.56% |